MannKind Corp
MNKD5.619USD
+0.229+4.25%
交易中 （美东）报价延迟15分钟
1.72B总市值
52.48市盈率 TTM
关于 MannKind Corp 公司
MannKind Corporation 是一家生物制药公司。该公司专注于为内分泌和罕见肺病患者开发和商业化吸入治疗产品。其技术包括 Technosphere 干粉配方和 Dreamboat 吸入装置，可将药物输送到肺部深处，在那里药物可以局部发挥作用或进入全身循环。其产品包括 Afrezza（人胰岛素）吸入粉和 V-Go 可穿戴胰岛素输送装置。Afrezza（人胰岛素）吸入粉是一种吸入胰岛素，用于增强糖尿病成人患者的血糖控制。V-Go 可穿戴胰岛素输送装置为需要胰岛素的成人提供皮下胰岛素输注。其罕见肺病产品线包括 Tyvaso DPI（曲前列尼尔）吸入粉，用于治疗肺动脉高压 (PAH) 和与间质性肺病相关的肺动脉高压 (PH-ILD)。
公司简介
公司代码MNKD
公司名称MannKind Corp
上市日期Jul 28, 2004
CEODr. Michael E. Castagna, Pharm.D.
员工数量407
证券类型Ordinary Share
年结日Jul 28
公司地址1 Casper Street
城市DANBURY
上市交易所NASDAQ Global Market Consolidated
国家United States of America
邮编06810
电话18186615000
网址https://mannkindcorp.com/
公司代码MNKD
上市日期Jul 28, 2004
CEODr. Michael E. Castagna, Pharm.D.
公司高管
名称
名称/职务
职务
持股
持股变动
Dr. Michael E. Castagna, Pharm.D.
Dr. Michael E. Castagna, Pharm.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.71M
-6.09%
Dr. David B. Thomson, J.D., Ph.D.
Dr. David B. Thomson, J.D., Ph.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
621.22K
-5.74%
Mr. Steven B. Binder
Mr. Steven B. Binder
Director
Director
452.01K
-17.33%
Mr. Dominic (Nick) Marasco
Mr. Dominic (Nick) Marasco
President, Endocrine Business Unit
President, Endocrine Business Unit
333.43K
+32.31%
Mr. Anthony C. (Tony) Hooper
Mr. Anthony C. (Tony) Hooper
Independent Director
Independent Director
201.15K
+14.19%
Mr. Ronald J. Consiglio
Mr. Ronald J. Consiglio
Independent Director
Independent Director
118.43K
--
Ms. Jennifer Grancio
Ms. Jennifer Grancio
Independent Director
Independent Director
110.70K
--
Dr. Sabrina Kay
Dr. Sabrina Kay
Independent Director
Independent Director
107.03K
--
Ms. Christine Mundkur, J.D.
Ms. Christine Mundkur, J.D.
Independent Director
Independent Director
27.68K
--
Dr. James Samuel Shannon, M.D.
Dr. James Samuel Shannon, M.D.
Independent Chairman of the Board
Independent Chairman of the Board
24.46K
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. Michael E. Castagna, Pharm.D.
Dr. Michael E. Castagna, Pharm.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
1.71M
-6.09%
Dr. David B. Thomson, J.D., Ph.D.
Dr. David B. Thomson, J.D., Ph.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
621.22K
-5.74%
Mr. Steven B. Binder
Mr. Steven B. Binder
Director
Director
452.01K
-17.33%
Mr. Dominic (Nick) Marasco
Mr. Dominic (Nick) Marasco
President, Endocrine Business Unit
President, Endocrine Business Unit
333.43K
+32.31%
Mr. Anthony C. (Tony) Hooper
Mr. Anthony C. (Tony) Hooper
Independent Director
Independent Director
201.15K
+14.19%
Mr. Ronald J. Consiglio
Mr. Ronald J. Consiglio
Independent Director
Independent Director
118.43K
--
收入明细
单位: USD更新时间: 7月6日 周日
单位: USD更新时间: 7月6日 周日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
业务USD
名称
营收
占比
Product sales
47.79M
60.99%
Royalties
30.00M
38.29%
Services
558.00K
0.71%
地区USD
名称
营收
占比
United States
78.35M
100.00%
业务
地区
业务USD
名称
营收
占比
Product sales
47.79M
60.99%
Royalties
30.00M
38.29%
Services
558.00K
0.71%
股东统计
更新时间: 8月15日 周五
更新时间: 8月15日 周五
持股股东
股东类型
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
7.69%
The Vanguard Group, Inc.
5.90%
State Street Global Advisors (US)
3.50%
Geode Capital Management, L.L.C.
2.48%
Nitorum Capital, L.P.
2.29%
其他
78.15%
持股股东
持股股东
占比
BlackRock Institutional Trust Company, N.A.
7.69%
The Vanguard Group, Inc.
5.90%
State Street Global Advisors (US)
3.50%
Geode Capital Management, L.L.C.
2.48%
Nitorum Capital, L.P.
2.29%
其他
78.15%
股东类型
持股股东
占比
Investment Advisor
23.14%
Investment Advisor/Hedge Fund
17.87%
Hedge Fund
10.75%
Research Firm
3.13%
Individual Investor
1.74%
Bank and Trust
0.63%
Pension Fund
0.31%
Insurance Company
0.04%
Venture Capital
0.03%
其他
42.37%
机构持股
更新时间: 7月1日 周二
更新时间: 7月1日 周二
报告期
机构数
持股数
持股占比
持股变动
2025Q2
477
184.37M
60.10%
+2.23M
2025Q1
482
184.47M
60.73%
+2.52M
2024Q4
470
175.08M
57.68%
+5.91M
2024Q3
459
161.03M
58.24%
+6.62M
2024Q2
442
145.29M
52.88%
-4.76M
2024Q1
433
140.98M
52.03%
-8.31M
2023Q4
422
141.98M
52.59%
-12.51M
2023Q3
418
148.17M
55.00%
-3.06M
2023Q2
412
143.59M
53.56%
-12.28M
2023Q1
412
147.80M
55.93%
-4.58M
查看更多
股东持股明细
名称
持股数
占比
持股变动
变动比例
公告日期
BlackRock Institutional Trust Company, N.A.
21.45M
7.06%
+246.00K
+1.16%
Mar 31, 2025
The Vanguard Group, Inc.
17.26M
5.68%
+1.26M
+7.90%
Mar 31, 2025
State Street Global Advisors (US)
9.47M
3.12%
-477.80K
-4.80%
Mar 31, 2025
Geode Capital Management, L.L.C.
6.79M
2.23%
+411.83K
+6.46%
Mar 31, 2025
Nitorum Capital, L.P.
7.79M
2.56%
-961.61K
-10.99%
Mar 31, 2025
Two Sigma Investments, LP
7.11M
2.34%
+839.90K
+13.40%
Mar 31, 2025
Avoro Capital Advisors LLC
8.75M
2.88%
--
--
Mar 31, 2025
Millennium Management LLC
5.82M
1.92%
+2.38M
+68.90%
Mar 31, 2025
Qube Research & Technologies Ltd
3.24M
1.07%
+1.70M
+109.83%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
3.53M
1.16%
+567.14K
+19.17%
Mar 31, 2025
查看更多
持股ETF
机构名称
占比
暂无数据
分红派息
近5年累计派现
0.00
美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据
拆合股
公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
